PUTRAJAYA, March 21 (Bernama) — Sponsored clinical research in Malaysia recorded an exceptional performance in 2021, surpassing its previous years accomplishments, as highlighted in Clinical Research Malaysia’s (CRM) Annual Report 2021. The report was launched earlier today by the Minister of Health, YB Khairy Jamaluddin at the Ministry of Health complex in Putrajaya, witnessed by CRM Board of Directors and stakeholders.
The annual report detailed 215 new sponsored clinical research in the country, the highest annual number reported since CRM’s inception. In 2021, Malaysia moved a position up, now ranking second within Southeast Asia region after Singapore, in terms of the number of global industry sponsored studies. These record-high numbers were also reflected in the Gross National Income generated, with highest annual value of RM 226 million investment reported from new sponsored studies, contributing to a cumulative value of RM 834 million generated from sponsored research since 2012.
- OPEC+ To Raise Oil Output In December
- Hamas Handed Over Another Israeli Hostage’s Body To Red Cross
- Expo On China’s High-End Printing Technologies Held In Dubai
- Iraq Limits Agricultural Plan Due To Drought
- Yemen’s Houthis Declare General Mobilisation Amid Fears Of Possible Israeli Attack
- Indian Security Forces Killed Four Extremists In Manipur State
- U.S. Gov’t Shutdown Set To Break Record As Senate Again Fails To Pass Funding Bill
- Iraqi PM Says “National Consensus” Reached To Bring Weapons Under State Control
- Iraq, Türkiye Signed Executive Mechanism For Water Cooperation Agreement
- Over 127 Million Voters Registered For Bangladesh’s 13th General Election